Fusion of NUP214 to ABL1 on amplified episomes in T-ALL – implications for treatment

被引：0
|
作者：
K Stergianou
C Fox
N H Russell
机构：
[1] Nottingham City Hospital,Department of Cytogenetics
[2] Nottingham City Hospital,Department of Haematology
来源：
Leukemia | 2005年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1680 / 1681
页数：1
相关论文
共 50 条
  • [41] CHARACTERIZATION OF NUP214-ABL1 POSITIVE T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA REVEALS GENOMIC HETEROGENEITY OF THE FUSION GENE PRESENTATION
    Graux, C.
    Dastugue, N.
    Lafage, M.
    Mugneret, F.
    Struski, S.
    Gregoire, M. J.
    Nadal, N.
    Lippert, E.
    Stevens-Kroef, M.
    Vandenberghe, P.
    Michaux, L.
    Bosly, A.
    Wlodarska, I.
    Lahortiga, I.
    De Keersmaecker, K.
    Cools, J.
    Hagemeijer, A.
    Poirel, H. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 196 - 197
  • [42] Sequential Order of Genetic Events in NUP214-ABL1 Positive T-Cell Leukemia
    Pisecker, Markus
    Arzt, Lisa
    Konig, Margit
    Ullmann, Reinhard
    Strehl, Sabine
    BLOOD, 2008, 112 (11) : 715 - 716
  • [43] Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and NUP214-ABL1 fusion: A case report
    Chen, Yan
    Zhang, Li
    Huang, Jiankun
    Hong, Xiuli
    Zhao, Jiangning
    Wang, Zhao
    Zhang, Kejie
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (05) : 3979 - 3984
  • [44] Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy
    Nardi, Valentina
    McAfee, Steven L.
    Dal Cin, Paola
    Tsai, Harrison K.
    Amrein, Philip C.
    Hobbs, Gabriela S.
    Brunner, Andrew M.
    Narayan, Rupa
    Foster, Julia
    Fathi, Amir T.
    Hock, Hanno
    ONCOLOGIST, 2022, 27 (02): : 82 - 86
  • [45] ZMIZ1::ABL1 Fusion An Uncommon Molecular Event With Clinical Implications in Pediatric Cancer
    Booth, Kevin T. A.
    Schulte, Rachael R.
    Smith, Laurin
    Gao, Hongyu
    Stohler, Ryan A.
    Liu, Yunlong
    Reshmi, Shalini C.
    Vance, Gail H.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2025, 149 (02) : 159 - 164
  • [46] ABL1 gene amplification and aberration involving HOX11L2/TLX3 in T-acute lymphoblastic leukemia (T-ALL).
    Luno, Elisa
    Sanzo, Carmen
    Jonte, Fermin
    LLorente, Regina
    Fanjul, Emilia
    Gonzalez, Soledad
    Martinez, Araceli
    BLOOD, 2006, 108 (11) : 188B - 189B
  • [47] Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies
    Quintas-Cardama, A.
    Tong, W.
    Manshouri, T.
    Vega, F.
    Lennon, P. A.
    Cools, J.
    Gilliland, D. G.
    Lee, F.
    Cortes, J.
    Kantarjian, H.
    Garcia-Manero, G.
    LEUKEMIA, 2008, 22 (06) : 1117 - 1124
  • [48] Whole-exome sequencing reveals the subclonal expression of NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia
    Tsurusaki, Yoshinori
    Nagai, Jun-ichi
    Fujita, Sachio
    Sugiyama, Masanaka
    Nakamura, Wataru
    Hayashi, Akiko
    Miyagawa, Naoyuki
    Keino, Dai
    Yokosuka, Tomoko
    Iwasaki, Fuminori
    Hamanoue, Satoshi
    Shiomi, Masae
    Goto, Shoko
    Kurosawa, Kenji
    Goto, Hiroaki
    PEDIATRIC BLOOD & CANCER, 2020, 67 (01)
  • [49] Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies
    A Quintás-Cardama
    W Tong
    T Manshouri
    F Vega
    P A Lennon
    J Cools
    D G Gilliland
    F Lee
    J Cortes
    H Kantarjian
    G Garcia-Manero
    Leukemia, 2008, 22 : 1117 - 1124
  • [50] An atypical FISH pattern of the BCR::ABL1 fusion gene in a paediatric B-ALL patient
    Andreu, Sandra
    Lluisa Ramirez, Maria
    Zabala, Teresa
    Berbel, Carlos
    Salido, Marta
    Torrebadell, Montserrat
    Montesdeoca, Sara
    Sarrate, Edurne
    Camos, Mireia
    Luis Dapena, Jose
    Rives, Susana
    Cuatrecasas, Esther
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 264 - 264
12345